Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Operating Expenses: 2016-2024

Historic Operating Expenses for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to $367.6 million.

  • Organogenesis Holdings' Operating Expenses rose 19.46% to $130.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $334.1 million, marking a year-over-year decrease of 18.77%. This contributed to the annual value of $367.6 million for FY2024, which is 17.02% up from last year.
  • Per Organogenesis Holdings' latest filing, its Operating Expenses stood at $367.6 million for FY2024, which was up 17.02% from $314.1 million recorded in FY2023.
  • Over the past 5 years, Organogenesis Holdings' Operating Expenses peaked at $367.6 million during FY2024, and registered a low of $224.3 million during FY2020.
  • Its 3-year average for Operating Expenses is $335.1 million, with a median of $323.6 million in 2022.
  • As far as peak fluctuations go, Organogenesis Holdings' Operating Expenses increased by 25.26% in 2021, and later dropped by 2.92% in 2023.
  • Organogenesis Holdings' Operating Expenses (Yearly) stood at $224.3 million in 2020, then grew by 25.26% to $280.9 million in 2021, then increased by 15.17% to $323.6 million in 2022, then fell by 2.92% to $314.1 million in 2023, then rose by 17.02% to $367.6 million in 2024.